As the main human monocyte population, we focused on deeply characterizing the ex vivo phenotype of classical CD14+ monocytes in uninfected healthy individuals and patients with COVID-19 presenting with mild or moderate symptoms (1-2 or 3-4 WHO ordinal scale for COVID-19 severity, respectively) during the acute phase of disease (Dataset 1). This evidence concerns the gene CD14 and COVID-19.